
Makes analogue and signal-processing chips for industrial, automotive and communications customers.
Analog Devices at a glance: how it scores on value, growth, quality, health, shareholder returns and trend. The fuller the shape, the stronger the company. Behind each axis are six pass-or-fail checks from its filings, spelled out in the chapters below. Point at an axis to see them.
A mixed picture - strengths and real weaknesses - 21 of 36 checks passed.
What you pay today for what the business produces, measured against ADI's own history and its peers, never a universal rule.
Expensive against its own history and its sector - you're paying up for what you get.
→At 44.3x earnings, the market is paying +54% more than ADI's own 6-year median of 28.8x. Expectations are elevated, so more has to go right to justify the price. Today's multiple is the highest in the charted history.
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→At 44.3x earnings, the market is paying +54% more than ADI's own 6-year median of 28.8x. Expectations are elevated, so more has to go right to justify the price. Today's multiple is the highest in the charted history.
2.8%FCF yield today
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→At 2.8%, you get less cash per dollar of market value than the 6-year median of 4.8% - the market is charging more for the same cash.
Value asks what you pay for each dollar of earnings, sales or cash the business produces. A high multiple isn't automatically bad - fast growers earn theirs - but a price far above the company's own history means the market expects a lot to go right. We compare each multiple to the company's own past and to its sector, never to a universal rule.
| – | Cheaper than its own history (earnings) | no multiple history |
| ✕ | Earnings yield beats a long bond (4%) | 2.3% vs 4.0% |
| – | Better cash yield than its own history | under 3 years of cash-flow history |
| ✕ | Free cash flow yield above 3% | 2.8% vs 3.0% |
| ✕ | Cheap on enterprise value | 33.67 vs 14.00 (peer median) |
| ✕ | Price isn't outrunning growth | PEG 1.71 |
What the company has actually reported - is it selling more, and is more of it becoming profit?
Growing, but with caveats - revenue - over the last year.
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Revenue reached $12.3B in 2023, compounding +30% a year since 2020 and the pace is picking up. The trailing twelve months are already running at $13.9B, ahead of the last full year.
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→Net income was $3.3B in 2023, compounding +40% a year over three years. Trailing twelve-month profit stands at $4.1B.
+2%revenue growth, FY 2023
→In 2023 revenue grew +2% while earnings moved +21% - when the earnings line runs above revenue, each new dollar of sales is arriving more profitably.
Growth here is what the company has actually reported to the SEC - not a forecast. We look at the last year, the three-year pace, whether growth is speeding up or slowing down, and whether it's been consistent rather than one lucky year. Hatched bars are fourth quarters we derived from annual filings (companies file a full-year 10-K rather than a Q4 report).
| – | Outgrew its sector last year | under 8 quarters of history |
| ✓ | Sustained growth beats its sector (3 years) | 30.0% vs 10.3% (sector 70th pct, n=156) |
| ✓ | Profits grew last year | swung to a profit of $4.1B from a loss |
| ✓ | Profit growth beats its peers | 25.9% vs 13.0% (sector 70th pct, n=81) |
| – | Growth is speeding up, not slowing | under 3 years of history |
| ✓ | Grew per share, not just in total | 61.5% vs 0.0% |
Whether the growth makes real money - margins, returns on capital, and whether profits turn into cash.
Rare profitability: margins and returns on capital are well above its peers.
◌ 2026 = trailing twelve months to the latest filed quarter (2026-08-01), not a full fiscal year
→Operating margin widened 4 points to 31% since 2020. After everything, 27 cents of each sales dollar reaches net profit.
◌ 2026 = trailing twelve months to the latest filed quarter (2026-08-01), not a full fiscal year
→Operating cash flow runs at 134% of reported profit, so the earnings are more than backed by cash - depreciation and other non-cash charges are understating what the business actually collects.
◌ 2026 = trailing twelve months to the latest filed quarter (2026-08-01), not a full fiscal year
→ROE 9% and ROCE 8% sit close together - the returns come from the business itself, not from borrowing.
→Of $12.3B in sales, $7.9B survives production costs, $3.8B survives running the company, and $3.3B - 27¢ of every dollar - reaches the bottom line.
◌ 2026 = trailing twelve months to the latest filed quarter, not a full fiscal year
→29 cents of every sales dollar became free cash in 2023, down 4 points since 2020.
◌ 2026 = trailing twelve months to the latest filed quarter (2026-08-01), not a full fiscal year
→The biggest claim on each sales dollar is research and development, at 13% of revenue (capital spending 10%, stock compensation 2%). That share has fallen since 2020, so the cost of competing is easing.
→Operating profit outgrew revenue in 3 of the last 5 years, most recently +17% against +2%. Each additional dollar of sales is landing more profitably than the last - the definition of operating leverage.
→ADI earns 8.4% on the capital it employs, below the 10% most investors treat as the cost of capital. It was 7.6% in 2020, so the trend is up, though the pace has cooled.
Quality asks whether the growth makes real money. Margins show how much of each sale survives costs; return on equity shows what shareholders earn on their capital; and the profit-to-cash comparison catches companies whose accounting profits never turn into actual cash.
| ✓ | Better gross margins than peers | 65.8% vs 44.7% (sector 70th pct, n=155) |
| ✓ | Runs leaner than peers (operating margin) | 35.5% vs 8.5% (sector 70th pct, n=161) |
| ✓ | Actually profitable | TTM net income $4.1B |
| ✓ | Earns well on shareholders' money | 12.3% vs 11.6% (sector 70th pct, n=149) |
| ✓ | Earns a real return on the capital it employs | 11.5% vs 10.0% |
| ✓ | Profits are cash, not accounting | 1.34 vs 0.80 |
The balance sheet stress test: could ADI survive a bad year?
Financially sound overall, with one or two things worth watching.
→Debt of $8.1B sits against $3.3B of cash, or 0.2x shareholders' equity. Earnings cover the interest bill 14 times over, so the debt is comfortably serviced.
→The company's own capital shrank from $35.5B in 2023 to $33.6B (-6%). Buybacks or losses are drawing the buffer down - the distinction matters.
Health asks one question: can the business survive a bad year? We check whether near-term bills are covered, whether debt is modest and shrinking, whether earnings comfortably pay the interest, and - for loss-makers - how many years of cash are left at the current burn rate.
| ✕ | Comfortable near-term liquidity | 1.25 vs 1.50 |
| ✓ | Debt isn't dominating | 0.24 vs 1.00 |
| ✕ | Debt trending the right way | debt/equity 0.24 now vs 0.17 five years ago |
| ✓ | Earnings cover the interest | 14.07 vs 5.00 |
| ✓ | Converts sales to cash better than its sector | 39.9% vs 16.8% (sector 70th pct, n=166) |
| ✓ | Self-funding | TTM free cash flow $4.9B |
How much cash actually flows back to owners - dividends, buybacks, whether the share count truly falls, and whether what is handed back is affordable.
Cash does come back to owners, but the share count is still climbing - part of it is recycling.
→$4.6B returned last year against $300M of stock issued to employees - the returns outweigh the dilution 15.5-to-1.
→The count shrank 3.3% last year - buybacks are outrunning stock compensation.
→Up from $1.64 to $3.32 per share over 7 years - the cheque keeps growing.
◌ 2026 = at the latest close (2026-09-04), over the trailing twelve months; earlier years are annual averages
→At today's price the yield is 1.0%.
◌ 2026 = trailing twelve months to the latest filed quarter (2026-08-01), not a full fiscal year
→Comfortable: 51% of profits and 47% of free cash flow go out as dividends - well inside what the business generates.
Both lines start at 100 in 2009, so the gap between them is what each share gained or lost. Share counts are split-adjusted.
→ADI issued +73% more shares from 2009 to 2023, but revenue per share still rose +253%. The dilution bought more growth than it cost existing holders.
A company can trumpet billions in buybacks while quietly issuing nearly as much stock to employees. What matters to you is the net effect: is the share count actually falling? If not, the 'return' is mostly recycling.
| ✕ | Share count isn't climbing | shares up 36.0% over 3 years |
| ✓ | Buybacks outpace the stock issued to staff | $3.1B bought back vs $350M of stock compensation |
| ✕ | What it hands back fits inside its cash flow | 104.7% vs 100.0% |
| ✓ | Meaningful yield to owners (dividends and buybacks) | $5.2B returned, 2.9% of market value |
| ✓ | Reliable payer, never cut | paid 10/10 years, worst year-on-year change 4.5% |
| ✓ | Dividend growing ahead of inflation | 89.5% vs 9.0% |
What the market is doing about all of the above. This is price behaviour, not a fact about the business - read it as the market's current opinion, scored on six checks like every other chapter. The market is the S&P 500, measured by the SPY ETF with dividends included, over 3 months (63 trading sessions) and 12 months (252).
Mixed signals from the market - some trends up, some rolling over.
Chart by TradingView
→ADI is in a downtrend. The price is below the band where recent trading settled and that band is still falling, so nothing in the picture has turned yet. Both the last two weeks and the month-ago comparison point down as well, so nothing here disagrees with the downtrend.
The trend read comes from the daily Ichimoku picture, a standard trend indicator, translated out of its jargon. It builds a band from the midpoints of the last 9, 26 and 52 sessions' highs and lows - in effect, the range where recent trading has settled - and draws that band 26 sessions into the future. Price above the band is an uptrend, below it a downtrend, inside it no trend. Because the band is drawn forward, the support for the next few weeks is already fixed and a change of its direction can be seen coming. We also compare the last two weeks against the last month, and today's price against where it stood a month ago. None of this says anything about the business; it describes the price only, and it is not advice. Where a check says 'the S&P 500', the comparison is with the SPY ETF including dividends, on the same adjusted basis as the stock's own price: short means 3 months, 63 trading sessions; long means 12 months, 252.
| ✕ | Trading above its cloud | 0.00 vs 0.50 |
| ✓ | Long-term trend structure is healthy | 376.31 vs 346.29 |
| ✕ | Rising over 3 months | -9.5% vs 0.0% |
| ✕ | Beating the S&P 500 over 3 months | -9.5% vs 4.7% |
| ✓ | Beating the S&P 500 over 12 months | 49.0% vs 20.0% |
| ✓ | Not in a deep hole | -18.4% from its 52-week high |
What the people running the company do with their own shares - reported to the SEC within two days, classified so pay-plumbing doesn't masquerade as conviction.
→No open-market buying, and $16M of selling across 6 months. Selling alone is a weak signal - much of it is pre-scheduled - but the absence of buying tells you no insider saw the price as a bargain.
| Date | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-01 | Vincent Roche | Chair & CEO | exercise | 10,000 | $1M |
| 2026-09-01 | Vincent Roche | Chair & CEO | SELL | 10,000 | $4M |
| 2026-08-27 | Karen Golz | Director | SELL | 1,000 | $374,500 |
| 2026-08-26 | Richard C Jr Puccio | EVP and CFO | SELL | 2,683 | $1M |
| 2026-08-17 | Michael Sondel | CAO (principal acct. officer) | tax | 237 | $92,652 |
| 2026-08-17 | Vincent Roche | Chair & CEO | tax | 2,878 | $1M |
| 2026-08-17 | Richard C Jr Puccio | EVP and CFO | tax | 1,108 | $432,502 |
| 2026-08-17 | Katsufumi Nakamura | SVP, Chief Customer Officer | tax | 202 | $78,688 |
| 2026-08-17 | Vivek Jain | EVP, Global Operations | tax | 1,111 | $433,627 |
| 2026-08-17 | Martin Cotter | SVP, Vertical Business Units | tax | 705 | $275,126 |
Most insider filings are not trades: stock grants, option exercises and tax withholding are how executives get paid, and gifts are estate planning. The signal lives in open-market transactions - a buy means an insider chose to spend their own cash on the stock. Sells are murkier: many are pre-scheduled 10b5-1 plans set months in advance. That's why the chart counts only open-market activity, and the table labels every row.